Clinical Trial Update: Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

View source ↗

Summary

This clinical trial update reports on HIV-1 patients virologically suppressed on ritonavir-boosted protease inhibitors who switched to cobicistat-boosted daruna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rezolsta (darunavir/cobicistat)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Human Immunodeficiency Virus | Status: COMPLETED